Global Viral and Non-viral Vector Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Viral and Non-viral Vector market size will reach 1,117.07 Million USD in 2025 and is projected to reach 2,739.06 Million USD by 2032, with a CAGR of 13.67% (2025-2032). Notably, the China Viral and Non-viral Vector market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Viral and non-viral vectors are tools used in gene therapy and genetic engineering to deliver genetic material into cells. Viral vectors are derived from viruses and utilize their natural ability to infect cells and transfer genetic material, making them highly efficient in gene delivery. These vectors are modified to be safe, removing the virus’s ability to cause disease while retaining their ability to insert the desired genes into the target cells. Common viral vectors include adenoviruses, lentiviruses, and adeno-associated viruses. Non-viral vectors, on the other hand, are synthetic delivery systems that do not involve viruses. These vectors can include liposomes, nanoparticles, and plasmids, which deliver genetic material through mechanisms like cell membrane fusion or endocytosis. While non-viral vectors are generally considered safer with fewer immune responses, they tend to be less efficient in gene delivery compared to viral vectors.
The major global suppliers of Viral and Non-viral Vector include Boehringer Ingelheim, Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica Plc, Sartorius AG, Takara Bio Inc., Thermo Fisher Scientific Inc., Wuxi AppTec, Acuitas Therapeutics, Evonik Industries AG, Exelead, Inc., Entos Pharmaceuticals, Genevant Sciences GmbH, T&T Scientific Corporation, Moderna, Inc., CureVac N.V., etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Viral and Non-viral Vector. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Viral and Non-viral Vector market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Viral and Non-viral Vector market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Viral and Non-viral Vector industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Viral and Non-viral Vector Include:
Boehringer Ingelheim
Catalent, Inc.
FUJIFILM Holdings Corporation
Danaher Corporation
Genscript Biotech Corporation
Lonza Group AG
Merck KGaA Inc.
Oxford Biomedica Plc
Sartorius AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Wuxi AppTec
Acuitas Therapeutics
Evonik Industries AG
Exelead, Inc.
Entos Pharmaceuticals
Genevant Sciences GmbH
T&T Scientific Corporation
Moderna, Inc.
CureVac N.V.
Viral and Non-viral Vector Product Segment Include:
Viral Vectors
Non-Viral Vectors
Viral and Non-viral Vector Product Application Include:
Gene Therapy
Vaccinology
Cell Therapy
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Viral and Non-viral Vector Industry PESTEL Analysis
Chapter 3: Global Viral and Non-viral Vector Industry Porter's Five Forces Analysis
Chapter 4: Global Viral and Non-viral Vector Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Viral and Non-viral Vector Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Viral and Non-viral Vector Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Viral and Non-viral Vector Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Viral and Non-viral Vector market size will reach 1,117.07 Million USD in 2025 and is projected to reach 2,739.06 Million USD by 2032, with a CAGR of 13.67% (2025-2032). Notably, the China Viral and Non-viral Vector market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Viral and non-viral vectors are tools used in gene therapy and genetic engineering to deliver genetic material into cells. Viral vectors are derived from viruses and utilize their natural ability to infect cells and transfer genetic material, making them highly efficient in gene delivery. These vectors are modified to be safe, removing the virus’s ability to cause disease while retaining their ability to insert the desired genes into the target cells. Common viral vectors include adenoviruses, lentiviruses, and adeno-associated viruses. Non-viral vectors, on the other hand, are synthetic delivery systems that do not involve viruses. These vectors can include liposomes, nanoparticles, and plasmids, which deliver genetic material through mechanisms like cell membrane fusion or endocytosis. While non-viral vectors are generally considered safer with fewer immune responses, they tend to be less efficient in gene delivery compared to viral vectors.
The major global suppliers of Viral and Non-viral Vector include Boehringer Ingelheim, Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica Plc, Sartorius AG, Takara Bio Inc., Thermo Fisher Scientific Inc., Wuxi AppTec, Acuitas Therapeutics, Evonik Industries AG, Exelead, Inc., Entos Pharmaceuticals, Genevant Sciences GmbH, T&T Scientific Corporation, Moderna, Inc., CureVac N.V., etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Viral and Non-viral Vector. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Viral and Non-viral Vector market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Viral and Non-viral Vector market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Viral and Non-viral Vector industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Viral and Non-viral Vector Include:
Boehringer Ingelheim
Catalent, Inc.
FUJIFILM Holdings Corporation
Danaher Corporation
Genscript Biotech Corporation
Lonza Group AG
Merck KGaA Inc.
Oxford Biomedica Plc
Sartorius AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Wuxi AppTec
Acuitas Therapeutics
Evonik Industries AG
Exelead, Inc.
Entos Pharmaceuticals
Genevant Sciences GmbH
T&T Scientific Corporation
Moderna, Inc.
CureVac N.V.
Viral and Non-viral Vector Product Segment Include:
Viral Vectors
Non-Viral Vectors
Viral and Non-viral Vector Product Application Include:
Gene Therapy
Vaccinology
Cell Therapy
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Viral and Non-viral Vector Industry PESTEL Analysis
Chapter 3: Global Viral and Non-viral Vector Industry Porter's Five Forces Analysis
Chapter 4: Global Viral and Non-viral Vector Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Viral and Non-viral Vector Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Viral and Non-viral Vector Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Viral and Non-viral Vector Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Viral and Non-viral Vector Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Viral and Non-viral Vector Product by Type
- 1.2.1 Viral Vectors
- 1.2.2 Non-Viral Vectors
- 1.3 Viral and Non-viral Vector Product by Application
- 1.3.1 Gene Therapy
- 1.3.2 Vaccinology
- 1.3.3 Cell Therapy
- 1.3.4 Others
- 1.4 Global Viral and Non-viral Vector Market Size Analysis (2020-2032)
- 1.5 Viral and Non-viral Vector Market Development Status and Trends
- 1.5.1 Viral and Non-viral Vector Industry Development Status Analysis
- 1.5.2 Viral and Non-viral Vector Industry Development Trends Analysis
- 2 Viral and Non-viral Vector Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Viral and Non-viral Vector Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Viral and Non-viral Vector Market Analysis by Country
- 4.1 Global Viral and Non-viral Vector Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Viral and Non-viral Vector Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Viral and Non-viral Vector Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.5 China Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.6 France Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.14 India Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Viral and Non-viral Vector Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Viral and Non-viral Vector Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Viral and Non-viral Vector Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Viral and Non-viral Vector Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Viral and Non-viral Vector Market Analysis by Type
- 6.1 Global Viral and Non-viral Vector Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Viral and Non-viral Vector Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Boehringer Ingelheim
- 7.1.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Boehringer Ingelheim Viral and Non-viral Vector Product Portfolio
- 7.1.3 Boehringer Ingelheim Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Catalent, Inc.
- 7.2.1 Catalent, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Catalent, Inc. Viral and Non-viral Vector Product Portfolio
- 7.2.3 Catalent, Inc. Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 FUJIFILM Holdings Corporation
- 7.3.1 FUJIFILM Holdings Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 FUJIFILM Holdings Corporation Viral and Non-viral Vector Product Portfolio
- 7.3.3 FUJIFILM Holdings Corporation Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Danaher Corporation
- 7.4.1 Danaher Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Danaher Corporation Viral and Non-viral Vector Product Portfolio
- 7.4.3 Danaher Corporation Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Genscript Biotech Corporation
- 7.5.1 Genscript Biotech Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Genscript Biotech Corporation Viral and Non-viral Vector Product Portfolio
- 7.5.3 Genscript Biotech Corporation Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Lonza Group AG
- 7.6.1 Lonza Group AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Lonza Group AG Viral and Non-viral Vector Product Portfolio
- 7.6.3 Lonza Group AG Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Merck KGaA Inc.
- 7.7.1 Merck KGaA Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Merck KGaA Inc. Viral and Non-viral Vector Product Portfolio
- 7.7.3 Merck KGaA Inc. Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Oxford Biomedica Plc
- 7.8.1 Oxford Biomedica Plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Oxford Biomedica Plc Viral and Non-viral Vector Product Portfolio
- 7.8.3 Oxford Biomedica Plc Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Sartorius AG
- 7.9.1 Sartorius AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Sartorius AG Viral and Non-viral Vector Product Portfolio
- 7.9.3 Sartorius AG Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Takara Bio Inc.
- 7.10.1 Takara Bio Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Takara Bio Inc. Viral and Non-viral Vector Product Portfolio
- 7.10.3 Takara Bio Inc. Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Thermo Fisher Scientific Inc.
- 7.11.1 Thermo Fisher Scientific Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Thermo Fisher Scientific Inc. Viral and Non-viral Vector Product Portfolio
- 7.11.3 Thermo Fisher Scientific Inc. Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Wuxi AppTec
- 7.12.1 Wuxi AppTec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Wuxi AppTec Viral and Non-viral Vector Product Portfolio
- 7.12.3 Wuxi AppTec Viral and Non-viral Vector Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Acuita
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
